3rd Quarter - Report

PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 112 (112th)

Pharmacy PHA

Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2516 (112th), H.R. 6433 (112th), H.R. 5651 (112th), S. 2292 (112th), S. 3187 (112th)

Medical/Disease Research/Clinical Labs MED

Diabetes research issues.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.